These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 18570094)

  • 41. The IRB's role in assessing the generalizability of non-NIH-funded clinical trials.
    Weijer C
    IRB; 1998; 20(2-3):1-5. PubMed ID: 11656912
    [No Abstract]   [Full Text] [Related]  

  • 42. Respect as an organizing normative category for research ethics.
    McGuire AL; McCullough LB
    Am J Bioeth; 2005; 5(1):W1-2. PubMed ID: 16036642
    [No Abstract]   [Full Text] [Related]  

  • 43. For whose protection? Another moral model.
    Newton LH
    IRB; 1983; 5(3):9-10. PubMed ID: 11649519
    [No Abstract]   [Full Text] [Related]  

  • 44. Proposed guidelines for the participation of persons with dementia as research subjects.
    Keyserlingk EW; Glass K; Kogan S; Gauthier S
    Perspect Biol Med; 1995; 38(2):319-61. PubMed ID: 11644666
    [No Abstract]   [Full Text] [Related]  

  • 45. Protecting vulnerable research subjects: practical realities of institutional review board review and approval.
    Wichman A
    J Health Care Law Policy; 1998; 1(1):88-104. PubMed ID: 15573431
    [No Abstract]   [Full Text] [Related]  

  • 46. "You don't know me, but …": access to patient data and subject recruitment in human subjects research.
    Schonfeld T; Brown JS; Amoura NJ; Gordon B
    Am J Bioeth; 2011 Nov; 11(11):31-8. PubMed ID: 22047124
    [No Abstract]   [Full Text] [Related]  

  • 47. Ethical human-research protections: not universal and not uniform.
    Fleming DA; Reynolds D
    Am J Bioeth; 2008 Nov; 8(11):21-2. PubMed ID: 19061102
    [No Abstract]   [Full Text] [Related]  

  • 48. Current status of the research ethics committees in Thailand.
    Panichkul S; Mahaisavariya P; Morakote N; Condo S; Caengow S; Ketunpanya A
    J Med Assoc Thai; 2011 Aug; 94(8):1013-8. PubMed ID: 21863687
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gather ye shibboleths while ye may.
    Fost N
    Am J Bioeth; 2005; 5(5):14-5. PubMed ID: 16179297
    [No Abstract]   [Full Text] [Related]  

  • 50. Response to open peer commentaries on "Social contexts influence ethical considerations of research".
    Levine RJ; Gordon JB; Mazure CM; Rubin PE; Schaller BR; Young JL
    Am J Bioeth; 2011 May; 11(5):W1-2. PubMed ID: 21534134
    [No Abstract]   [Full Text] [Related]  

  • 51. A quartet of criticisms.
    Vanderpool HY
    Am J Bioeth; 2005; 5(5):16-9. PubMed ID: 16179299
    [No Abstract]   [Full Text] [Related]  

  • 52. Creative solutions: research subject advocates: increase in reports of human subject protection deficiencies bring scrutiny as well as more efforts at education and support.
    O'Lonergan T
    Prot Hum Subj; 2003; (8):10-1. PubMed ID: 16178110
    [No Abstract]   [Full Text] [Related]  

  • 53. Guidelines for addressing ethical and legal issues in Alzheimer disease research: a position paper.
    High DM; Whitehouse PJ; Post SG; Berg L
    Alzheimer Dis Assoc Disord; 1994; 8(Suppl. 4):66-74. PubMed ID: 11657676
    [No Abstract]   [Full Text] [Related]  

  • 54. Experts at the benchside.
    Saunders PT
    Am J Bioeth; 2008 Mar; 8(3):20-1; discussion W4-6. PubMed ID: 18570092
    [No Abstract]   [Full Text] [Related]  

  • 55. Estimating risks and benefits in AIDS vaccine and drug trials.
    Kessel E
    AIDS Public Policy J; 1990; 5(4):186-8. PubMed ID: 11650977
    [No Abstract]   [Full Text] [Related]  

  • 56. Outsourcing ethical obligations: should the revised common rule address the responsibilities of investigators and sponsors?
    Shah SK
    J Law Med Ethics; 2013; 41(2):397-410. PubMed ID: 23802893
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Additional thoughts on rethinking research ethics.
    Sharp RR; Yarborough M
    Am J Bioeth; 2005; 5(1):40-2; author reply W15-8. PubMed ID: 16036657
    [No Abstract]   [Full Text] [Related]  

  • 58. A word to Varmus.
    Pryor D; Hatfield M; Wyden R; Waxman HA
    Hastings Cent Rep; 1996; 26(4):46-7. PubMed ID: 11644858
    [No Abstract]   [Full Text] [Related]  

  • 59. The limitations of "vulnerability" as a protection for human research participants.
    Levine C; Faden R; Grady C; Hammerschmidt D; Eckenwiler L; Sugarman J;
    Am J Bioeth; 2004; 4(3):44-9. PubMed ID: 16192138
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modernizing the Common Rule: Public Trust and Investigator Accountability.
    Hurley EA
    Am J Bioeth; 2017 Jul; 17(7):39-41. PubMed ID: 28661752
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.